,ug/ml and above) some organisms occasionally escaped death. None of the escaped organisms was resistant to MCR. In combination with other commonly used antibiotics, MCR displayed partial synergy for Pseudomonas aeruginosa (from a minimal inhibitory concentration of >100 to 12.5 ug/ml with 100 ,ug of chloraimphenicol per ml) and for Bacillus pumilus and Staphylococcus aureus (from 1.6 to 0.4 ,ug/ml and below) with polymyxin B. As with mammalian cells, 125I-labeled MCR was irreversibly bound to both gram-positive and -negative bacteria. Treatment with trypsin of the mI-labeled MCR-exposed cells did not release the bound MCR or reverse its lethal effect. When in solution in a protective buffer at 4°C, MCR was stable for up to 45 days; at 370C, however, 25% of its bactericidal activity was lost in 72 h. Loss of activity was enhanced 16-fold in the presence of both heated and unheated pooled human sera. Urine had no effect on the activity of MCR.
Macromomycin (MCR; NSC 170105) is an unstable, antitumor (7, (9) (10) (11) (12) polypeptide antibiotic discovered in 1968 by Chimura et al. (3) . Recently, Yamashita et al. (16) have shown that its activity can be stabilized by certain substances, in particular the disaccharides, lactose and maltose. This has facilitated the purification of MCR to homogeneity (J.L. Winkelhake and F.L.A. Buckmire, Cancer Res., in press).
As with other anititumor antibiotics recently isolated, the mode of action of MCR has not been studied in detail. Kunimoto et al. (6) and Winkelhake and Buckmire (Cancer Res., in press) have shown that radioiodine ('25I)-labeled MCR readily binds to mammalian cell surfaces and, presumably from that location, causes cessation of deoxyribonucleic acid (DNA), but not ribonucleic acid or protein, synthesis. Kunimoto et al. (7) have hypothesized that the interaction between MCR and the mammalian cells is analogous to the interaction between certain colicins and bacterial cells (4) .
Since the initial published data (3), there have been no other studies on the effect of MCR on bacteria. This communication compares the antimicrobial action of purified MCR on some gram-positive and -negative bacteria with several commonly used antibiotics. MATERIALS plates. H. influenzae was grown on TSA supplemented with oxidized nicotinamide adenine dinucleotide (P-S Biochemicals, Milwaukee, Wis.), recrystallized hemin (Nutritional Biochemicals Corp., Cleveland, Ohio), and glucose (Calbiochem, La Jolla, Calif.) (1, 5) , and S. serpens was cultivated on a Casamino Acids-salt medium containing agar (Difco Laboratories, Detroit, Mich.) (2) . For all experiments, cultures were grown at 37°C for 8 to 14 h, harvested, and suspended in either the growth medium or HEPES (N-2-hydroxyethyl piperazine-N'-2-ethanesulfonic acid) buffer. Cultures (excluding H. MCR. MCR was purified by sequential salt precipitation, ultrafiltration, ion exchange and molecular sieve chromatographies, and stabilized during lyophilization in 1% lactose-phosphate-buffered saline (Lac-PBS), pH 7.2, by a modification (Winkelhake and Buckmire, Cancer Res., in press) of the procedure of Yamashita et al. (16) . During purification, fractions were monitored for activity by an agar-plate bacteriocidal technique, with B. pumilus as the test organism. Preparation homogeneity was determined by sodium dodecyl sulfate-polyacrylamide slab-gel electrophoresis, using 12.5% gel by the method of Laemli (8) . A single protein band, which migrated between ribonuclease (13,700 daltons) and lysozyme (11,400 daltons) standards, was obtained. Since the electrophoresis technique employed is sensitive to about 10 ,ug of protein, our preparation was estimated to be >97% pure. Drug concentrations were determined spectrophotometrically with an 11.6 absorbancy value at 280 nm equivalent to 1%. Purified MCR was stored lyophilized in Lac-PBS at -70°C with no apparent loss of activity.
MCR was radioiodinated with cellulose-immobilized lactoperoxidase (15; Winkelhake and Buckmire, Cancer Res., in press). Gamma radiation was monitored by a Beckman GM100 gamma counter with a data computer. The specific activity of 125I_ labeled MCR was 4 ± 0.5 x 106 cpm/mg. lodination did not cause loss of bactericidal activity.
Other antibiotics. Actinomycin D, bacitracin, chloramphenicol, penicillin G, polymyxin B, and tetracycline were obtained from Calbiochem, La Jolla, Calif.; streptomycin sulfate came from E. R. Squibb & Sons, New York, N.Y.; gentamicin reagent was obtained from Schering Laboratories, Bloomfield, N.J.; and bleomycin sulfate (Blenoxane) was from Bristol Laboratories, Syracuse, N.Y.
Stock solutions (1 to 2.5 mg/ml) of all antibiotics were prepared in sterile glass with distilled water (weight corrected for potency) and then sterilized by membrane filtration (pore size, 0.2 ,um; Gelman Instrument Co., Ann Arbor, Mich.). Appropriate dilutions were made in sterile TSB to yield 100 or 250 ,ug of each drug per ml.
Broth dilution susceptibility tests. Serial twofold broth dilution tests were performed in the growth medium in a volume of 1 ml per tube. Cultures for these experiments were grown on agar plates, harvested in the growth medium without agar, adjusted to an optical density of between 0.4 and 0.55 at 600 nm, and diluted 100-to 1,000-fold to produce a final bacterial population in each tube of 106 to 107 colonyforming units (CFU) per ml.
The minimal inhibitory concentration (MIC) was defined as the lowest concentration of drug that prevented macroscopic growth after incubation of 18 to 24 h at 37°C. Minimal bactericidal concentration (MBC) was determined by subculturing 1 ,ul (calibrated loop) from each clear tube onto a TSA plate. The MBC was defined as the lowest drug concentration preventing all growth on subculture.
Kill curves. Side arm flasks containing MCR in TSB were inoculated with an appropriate dilution of B. pumilus suspension to produce a final bacterial population of approximately 107 CFU/ml and incubated at 30°C while shaking. Samples were removed at various time intervals, diluted in TSB, and plated in triplicate on TSA plates. Antibiotic inactivation test. HEPES buffer (0.01 M, pH 7.55) containing MCR was inoculated with approximately 108 CFU/ml of B. pumilus and incubated for 30 min at 37°C. After centrifugation at 7,500 x g for 10 min, the pelleted cells were washed twice and plated. The supernatant obtained after initial centrifugation was filter sterilized (pore size, 0.2 ,um; Gelman Instrument Co., Ann Arbor, Mich.), reinoculated with 108 CFU/ml, and, after incubation at 37°C for 30 min, plated on TSA plates. As a control, the above procedure was simultaneously performed on cells suspended in buffer without MCR.
Synergy. To test for synergy, serial twofold tube dilutions of MCR were made as described above, and, to each dilution, the same concentration of a second antibiotic was added. Three different concentrations of the second antibiotic were used. Synergy was defined as a reduction of the MIC values of both antibiotics by fourfold or more. Partial synergy was defined as a fourfold or greater reduction in the MIC value of one compound but less than fourfold reduction in the MIC value of the second antibiotic. Indifference to combined antibiotics was defined as a twofold or less reduction in MIC values. Antagonism was defined as a fourfold increase in the MIC value of either antibiotic.
125I-labeled MCR binding experiments. Bacterial cell suspensions in HEPES buffer with and without 125I-labeled MCR were incubated either at 4 or 37°C for various time intervals. After incubation, the suspensions were centrifuged at 7,500 x g for 10 min, and the pelleted cells, washed twice with cold HEPES buffer to remove unbound MCR, were resuspended to the original. volume in HEPES buffer.
These suspensions were again incubated at either 4 or 37°C in the presence and absence of 1% trypsin for up to 30 min and centrifuged, and the pellet was resuspended to the original volume in HEPES buffer. Both the supernatants and cell suspensions were quantitatively analyzed for radioactivity. In cases where CFU determinations were to be made, sterile materials were used throughout. Serial dilutions were made in TSB, and the CFU values were determined on TSA plates.
Chemicals and buffers. All chemicals were of reagent grade. The HEPES buffer concentration throughout this study was 10 mM, pH 7.55. PBS contained 10 mM Na2HPO4, 150 mM NaCl, 1 mM CaCl2, and 0.5 mM MgCl2. 6H20, pH 7.2. Lac-PBS contained 1% lactose in PBS.
RESULTS
Antibacterial effects of MCR. MCR displayed strong antibacterial effects against some gram-positive and -negative bacteria (Table 1) . It was, however, much more effective against the gram-positive bacteria. The MIC was below VOL. 11, 1977 on November 1, 2017 by guest http://aac.asm.org/ When compared with some other commonly used antibiotics, the MIC of MCR was lower than the majority against the gram-positive organisms tested (Table 1) . Although its activity compared favorably with the other antibiotics tested against the gram-negative bacterium S. serpens, it was not as effective as gentamicin, streptomycin, tetracycline, chloramphenicol, polymyxin B, and bleomycin againstE. coli or gentamicin, tetracycline, and polymyxin B against P. aeruginosa. Additionally, the MBC of MCR was the same as the MIC for most organisms tested. S. aureus was the notable exception. MBC and MIC values were generally the same for all the bactericidal antibiotics.
Upon prolonged incubation at 370C, macroscopic culture growth occasionally occurred at concentrations higher than the MIC of MCR. Such growth may be explained (a) by the spontaneous mutation to resistant cells, (b) by inactivation of the antibiotic, or (c) by a prozonelike effect similar to that seen during antibodycomplement-mediated bactericidal activity (14) . Cells, isolated from growth at these higher MCR concentrations (50 to 100 ,ug/ml) and subcultured once, were as susceptible as the original culture, thus indicating they were not resistant mutants.
To determine whether the presence of other antibiotics could enhance the antibacterial activity of MCR, the MIC of MCR for two gramnegative and two gram-positive organisms was determined in the presence of various concentrations of other antibiotics. Table 2 shows that, for P. aeruginosa with the chloramphenicol concentration at 100 gg/ml, the MIC of MCR was reduced from >100 to 12.5 jug/ml. No similar synergistic or antagonistic effect was observed with the other antibiotics against either P. aeruginosa or E. coli. With gram-positive organisms, partial synergy was observed between polymyxin B and MCR. With B. pumilus, the MIC of MCR was reduced to 0.1 ,Ag/ml in the presence of 20 ,ug of polymyxin B per ml, and with S. aureus, the MIC was reduced to 0. 4 ,ug/ml in the presence of 100 ,ug of polymyxin B per ml.
Bactericidal activity of MCR. Table 3 shows the effect of exposure time on the ability of MCR to kill bacteria suspended in a nongrowth medium (HEPES buffer). At effective concentrations (1 ,ug/ml and above), the bactericidal effect of MCR was immediate on B. pumilus, whereas on S. aureus and S. serpens the effect was time dependent. This time-dependent effect varied with the concentration of the antibiotic used. For example with S. serpens, at a concentration of 1 ug/ml (about one-half of the MIC), there was no immediate killing-, however, after 20-min of incubation in the presence of the antibiotic, approximately 98% of the cells were killed. At 10 ,ug/ml (four times the MIC), immediate killing of 80% ofthe cells, increasing to about 99% within 20 min, occurred. Tested organisms always left a residual percentage of surviving cells, even after extensive exposure to the antibiotic. These surviving organisms did not form colonies when plated at the higher antibiotic concentrations (50 ,ug/ml and above), but as the MCR concentration decreased during serial dilutions to below the MIC for the culture growth occurred. Susceptibility tests on some of the surviving cells indicated that their resistance to the antibiotic had not changed. Microscopic observations also indicated no obvious qualitative or quantitative morphological differences in the treated and untreated cells.
To determine the influence of the suspending medium on bacteriostasis, growth media containing MCR were inoculated with B. pumilus, and the CFU was determined at various time intervals. After 5 min of exposure to MCR, the CFU had decreased to approximately 0.2% at the two concentrations (1 and 10 ug/ml) tested (Fig. 1) . At 10 jug/ml, the CFU continued to decrease, as a function of time, to approximately 0.02% in 24 h. At 1 ,ug/ml, however, there was a rapid recovery of cells, such that by 2 h the CFU was approximately 5% of the initial inoculum. Between 2 and 24 h, the growth rate was similar to that of the control culture. cell-bound MCR at 370C nor its antibacterial action was affected by treating the MCR-adsorbed cells with trypsin. Influence of cell concentration on the MIC. As other studies (13) on the influence of bacterial cell concentration on MIC show, inoculum size profoundly affected the MIC of MCR (Table  6 ). Whereas an inoculum of 107 CFU/ml gave an MIC of 1.6 ,ug/ml, 10-and 100-fold decreases in cell concentration gave MIC values of 0.39 and 0.1 j,g/ml, respectively, and 10-and 100-fold increases gave 12.5 and 50 jg/ml, respectively.
Stability of MCR in body fluids. Other workers (16) have shown that when MCR suspended in PBS was lyophilized it lost activity. This activity loss was enhanced by increasing the temperature. However, when certain divalent cations and disaccharides were added prior to lyophilization, the rate of inactivation was retarded. At 350C, for example, there was a 10% activity loss in 31 days when maltose was added, whereas almost all activity was lost in the absence of the protective agent (16) . Table 7 presents the effect of certain body fluids on the stability of MCR in solution. At 40C, no activity loss of MCR stabilized in Lac-PBS occurred for up to 45 days, the longest interval tested. At 370C, however, there was a 16-fold loss in activity by 96 h. The addition of urine to solubilized MCR had no effect on its activity. When serum (heated or unheated) was added, however, the inactivation rate greatly increased ( Table 7 ).
The logarithm plot of MCR residual activity yielded straight lines as a function of time for each of the suspending fluids, indicating a firstorder inactivation. DISCUSSION MCR used in this study was purified to homogeneity, which allowed us to unequivocally determine the antibacterial action of the drug. Homogeneity was facilitated with lactose as a stabilizing agent (Winkelhake and Buckmire, Cancer Res., in. press) during purification.
Stability studies on purified MCR dissolved in Lac-PBS buffer clearly indicate that the drug was unstable in solution at 37 but not at 4°C (Table 7) . However, since there was no significant reduction in MCR activity within 24 h at 370C, the MIC values we obtained are considered valid. Inactivation of MCR at 370C was also enhanced, and to the satme degree (at least 16-fold in 72 h), by both heated and unheated pooled human sera, thus indicating that this inactivation was probably not due to serumrelated enzymatic cleavage of the polypeptide. In their thermal inactivation studies on purified MCR, Yamashita and co-workers (16) calculated that the lyophilized powder in maltose would lose 10% of its activity in 31 days and 17 months at 35 and 40C, respectively.
Although the spectrum of the bacterial gen- As with mammalian cells (6; Winkelhake and Buckmire, Cancer Res., in press), small quantities of MCR bound irreversibly to bacterial cells within 10 to 20 min, and the adsorption was temperature independent. However, in contrast to mammalian cells, treatment of bacteria with trypsin either before or after exposure to MCR did not release the bound MCR or alter the lethal effect of the drug. Thus it seems that the mechanism governing the association between MCR and bacterial cells may be different from the surface receptor-specific association of mammalian cells postulated by Kunimoto et al. (7) and demonstrated by Nussey and Winkelhake (personal communication). The fundamental mode of action of MCR on mammalian cells (inhibition of DNA synthesis, [6; Winkelhake and Buckmire, Cancer Res., in press]) and bacterial cells (not as yet determined) may well be the same, however.
The time taken for the bactericidal effect of MCR to manifest varied with the organism used. With B. pumilus the effect was immediate, whereas with S. aureus and S. serpens at least a 10-min lag took place. This time difference in responses may represent a difference in the degree of surface control of DNA synthesis or in the cell wall porosity of the organisms, rather than a difference in the mode of antibiotic action.
There have been only a few studies on MCR antitumor effects (7, (9) (10) (11) (12) and possible modes of action (6, 7) . These studies suggested to Ku-VOL. 11, 1977 on November 1, 2017 by guest http://aac.asm.org/ nimoto et al. (7) that MCR may inhibit DNA s'nthesis while attached to eucaryotic cell surfaces by a mechanism analogous to that postulated for the interactions between certain colicins and E. coli (4) . The data presented so far, however, have not been unequivocal. The recent developments of a sensitive-specific assay for detection of minute quantities of the drug (Winkelhake and Buckmire, Cancer Res., in press) and the methodology to stabilize it (16) will undoubtedly stimulate more definite studies in these areas.
